Recent reports of suspected cases of monkeypox virus in some regions of Nigeria has brought this little known about virus into the spotlight. In this article, Obabiyi Ajao & Amara Anyogu discuss current knowledge about the disease caused by this virus and the reported outbreak in Nigeria.
What is monkeypox?
Orthopoxvirus; now that’s a word you don’t hear too often. Orthopoxviruses are a group of related viruses which infect a range of vertebrate animals. Unlike it’s more infamous cousin, smallpox, many people may not have heard about the monkeypox virus. However, since the global eradication of smallpox, monkeypox has become the most significant member of the Orthopoxviruses.
Monkeypox is a sporadic disease occurring primarily in remote parts of Central and West Africa. The disease was first observed in 1958 in experimental monkeys in Denmark but infections in humans were first described in 1970 in the Democratic Republic of Congo. Diseases like monkeypox which can be passed from animals to humans are called zoonoses.
The monkeypox virus has been reported to be transmitted through contact with animals infected with the virus and different animals such as monkeys, Gambian giant rats, squirrels and rodents have been implicated as important reservoirs of the virus. Infection results from direct contact with the blood, bodily fluids of infected animals. Eating undercooked meat of infected animals is also a risk factor. Its secondary spread through human-to-human transmission is limited but can occur as a result of prolonged exposure to infected persons primarily through respiratory tract secretions but also through contaminated objects. Monkeypox can also be transmitted through the placenta (congenital monkeypox). It causes death in about 1% -10% of affected victims, particularly children.
The period of time between infection and onset of symptoms is usually 5 – 21 days. Symptoms include fever, headache, back pain, muscle ache, lack of energy, and swelling of the lymph node within the first five days. The skin begins to erupt within 1- 3 days after the appearance of fever. The eruption evolves from lesions with flat bases (maculopapules) to vesicles (small fluid-filled blisters), pustules, followed by crusts within 10 days. The lesions affect the face and other parts of the body, including oral mucous membrane, genitalia and eyeball. A distinctive feature of monkeypox from other similar diseases is the appearance of swollen lymph nodes before the appearance of rash.
Currently, there is no treatment or vaccine available although smallpox vaccination was highly effective in preventing monkeypox, however the vaccine is not available after the successful vaccination programme to eradicate smallpox. Monkeypox is self-limiting and may last for about 14 – 21 days with severity depending on the age, exposure and health status of the patient. To confirm suspected cases of monkeypox, laboratory diagnosis is required. Laboratory tests include enzyme-linked immunosorbent assay (ELISA), antigen detection tests, polymerase chain reaction (PCR) assay and virus isolation by cell culture.
Monkeypox can be contained by placing restrictions on the consumption of risk animals and the immediate cull of potentially infected animals. More importantly, scientists and health professionals also have an important role in increasing community awareness of risk factors and educating people about the measures to be taken to reduce exposure to the virus e.g. maintaining adequate levels of hygiene, handwashing etc.
Nigerian outbreak
Monkeypox is endemic in Africa with most cases occurring in the Congo Basin. The most recent outbreak before the current outbreak in Nigeria was in Central African Republic in 2016, with 26 cases and 2 deaths recorded. The first case in the current outbreak in Nigeria was reported to the Nigerian Centre for Disease Control (NCDC) in September 2017. By the second week of October, of 17 cases reported in Yenagoa in Southern Nigeria, three were confirmed as testing positive for monkeypox infection prompting the NCDC to declare an outbreak in the region. This is the third human monkeypox outbreak in Nigeria, the first two recorded as occurring in 1971 and 1978.
The correct identification of patients is essential to ensure that appropriate medical treatment can be provided to patients and critically the deployment of efficient control measures. Infection with varicella zoster virus, the causative agent of chicken pox can have a similar presentation as monkeypox and in regions where monkeypox is endemic the two diseases can often be mistaken. An attempt to define specific clinical characteristics associated with laboratory confirmed cases was recently undertaken in a collaborative study between scientists based in the United States Centre for Disease Control and the Ministry of Health in Kinshasa.
Health systems must be able to provide adequate surveillance and means of rapid identification of the virus to contain any outbreak. Significant investment must be made in equipping our diagnostic laboratories and in improving the technical knowledge of our laboratory scientists to increase our capacity and competence to carry out these laboratory confirmations within the country. During the recent outbreak, samples had to be sent to the WHO lab in Dakar for laboratory confirmation of monkeypox and a significant percentage of suspected cases were not monkeypox. Delays between sample collection and confirmation can lead to anxiety and cause unnecessary panic to settle in communities with a high number of cases.
We must also invest in our scientific research institutions to improve our understanding of the virus, particularly the reservoirs of the virus in our country and how the disease spreads in animals. It is notable that further laboratory tests using whole genome sequencing are being conducted at the African Centre for Genomics and Infectious Diseases at Redeemer’s University in Ogun State. Is monkeypox an emerging virus? How related are the viruses circulating in Nigeria to those currently in Congo? Is there co-infection with varicella zoster as noted in other outbreaks? Our research is important in answering these important questions.
The Nigerian Applied Microbiologists group commends the efforts of the Nigerian Centre for Disease Control for the proactive response to the recent monkeypox outbreak, particularly for the establishment of the Emergency Operations Centre and for communicating and engaging with the public using various channels e.g. social media, Whatsapp, TV and radio.
References
Nigerian Centre for Disease Control (2017)
Osadebe et al., 2017. Enhancing case definitions for surveillance of human monkeypox in the Democratic Republic of Congo. PLoS Neglected Tropical Diseases.
Pauli et al., 2010. Orthopox viruses: Infections in Humans. Transfusion Medicine and Hemotherapy.
Vanguard (2017). https://www.vanguardngr.com/2017/10/return-monkey-pox-ailment-no-cure-39-years/